Hyperuricemia Clinical Trials
2 recruiting trials for Hyperuricemia. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 1NCT06629376
Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia
This is a safety, tolerability, pharmacokinetics, and preliminary pharmacological study of multiple administration, dose escalation, randomized double-blind,...
Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.Enrolling: 601 location
RECRUITINGPhase 2NCT07116746
Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients
This study will assess the effect of AR882 and XOI co-administration on sUA lowering as well as reducing tophus burden in the population that has failed uricase treatment (eg.,...
Sponsor: Arthrosi TherapeuticsEnrolling: 258 locations